BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25218771)

  • 1. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
    Lomtadze N; Kupreishvili L; Salakaia A; Vashakidze S; Sharvadze L; Kempker RR; Magee MJ; del Rio C; Blumberg HM
    PLoS One; 2013; 8(12):e83892. PubMed ID: 24367617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.
    Araújo-Mariz C; Lopes EP; Ximenes RA; Lacerda HR; Miranda-Filho DB; Montarroyos UR; Barreto S; Salustiano DM; Albuquerque MF
    J Med Virol; 2016 Jun; 88(6):996-1002. PubMed ID: 26580855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment.
    Chien JY; Huang RM; Wang JY; Ruan SY; Chien YJ; Yu CJ; Yang PC
    Int J Tuberc Lung Dis; 2010 May; 14(5):616-21. PubMed ID: 20392356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
    Merza MA; Haji SM; Alsharafani AM; Muhammed SU
    Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
    Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
    J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
    Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
    J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
    Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
    J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil.
    Aires RS; Matos MA; Lopes CL; Teles SA; Kozlowski AG; Silva AM; Filho JA; Lago BV; Mello FC; Martins RM
    J Clin Virol; 2012 Aug; 54(4):327-31. PubMed ID: 22608842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil.
    Costi C; Grandi T; Halon ML; Silva MS; Silva CM; Gregianini TS; Possuelo LG; Jarczewski CA; Niel C; Rossetti ML
    Mem Inst Oswaldo Cruz; 2017 Apr; 112(4):255-259. PubMed ID: 28327789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
    Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
    J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.